Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications.

Suppr

超能文献

作者信息

Chapman R English, Spinale Francis G

出版信息

Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H1-H10. doi: 10.1152/ajpheart.00609.2003.

DOI:10.1152/ajpheart.00609.2003

PMID:14684355

Abstract

摘要

相似文献

Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications.

Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H1-H10. doi: 10.1152/ajpheart.00609.2003.

The Myocardial Interstitium: The Principal Therapeutic Target of the 21st Century?心肌间质：21世纪的主要治疗靶点？

JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2369-2371. doi: 10.1016/j.jcmg.2019.10.002.

Considerations for Clinical Trials Targeting the Myocardial Interstitium.靶向心肌间质的临床试验考虑因素。

JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2319-2331. doi: 10.1016/j.jcmg.2019.03.034. Epub 2019 Aug 14.

Why Clinicians Should Care About the Cardiac Interstitium.为什么临床医生应该关注心脏间质。

JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2305-2318. doi: 10.1016/j.jcmg.2019.04.025. Epub 2019 Aug 14.

Biochemical characterization and cellular localization of serine protease in myopathic hamster.肌病仓鼠中丝氨酸蛋白酶的生化特性及细胞定位

J Mol Cell Cardiol. 1981 Dec;13(12):1035-49. doi: 10.1016/0022-2828(81)90294-7.

The role of alkaline protease in the development of cardiac lesions in myopathic hamsters: effect of verapamil treatment.碱性蛋白酶在肌病性仓鼠心脏病变发展中的作用：维拉帕米治疗的效果

Biochem Med. 1984 Oct;32(2):207-15. doi: 10.1016/0006-2944(84)90074-7.

Activation and release of degradative proteinases within the myocardium are the trigger for ventricular remodeling in chronic heart failure.心肌内降解蛋白酶的激活和释放是慢性心力衰竭心室重塑的触发因素。

Med Hypotheses. 2002 Jan;58(1):18-23. doi: 10.1054/mehy.2001.1420.

Extracellular proteolysis: new paradigms for an old paradox.

J Lab Clin Med. 1999 Oct;134(4):341-51. doi: 10.1016/s0022-2143(99)90148-8.

Myocardial Tissue Characterization of Left Ventricular Reverse Remodeling in Ischemic Cardiomyopathy.缺血性心肌病左心室逆向重构的心肌组织特征

Circ J. 2016 Nov 25;80(12):2427-2428. doi: 10.1253/circj.CJ-16-1115. Epub 2016 Nov 10.

Effect of pH and temperature on stability and kinetics of novel extracellular serine alkaline protease (70 kDa).pH 值和温度对新型细胞外丝氨酸碱性蛋白酶（70 kDa）稳定性和动力学的影响。

Int J Biol Macromol. 2013 Mar;54:1-8. doi: 10.1016/j.ijbiomac.2012.11.024. Epub 2012 Nov 28.

引用本文的文献

Infliximab Limits Injury in Myocardial Infarction.英夫利昔单抗限制心肌梗死损伤。

J Am Heart Assoc. 2024 May 7;13(9):e032172. doi: 10.1161/JAHA.123.032172. Epub 2024 May 3.

Association of matrix metalloproteinase-9 and nitric oxide with hypertension in obstructive sleep apnea.基质金属蛋白酶-9和一氧化氮与阻塞性睡眠呼吸暂停高血压的关联

Laryngoscope Investig Otolaryngol. 2022 Apr 25;7(3):885-893. doi: 10.1002/lio2.796. eCollection 2022 Jun.

Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia-reperfusion: relationship to interstitial microRNA dynamics and myocardial function.缺血再灌注时差异型基质金属蛋白酶 1 底物的处理：与细胞间 microRNA 动力学和心肌功能的关系。

J Thorac Cardiovasc Surg. 2013 Jan;145(1):267-275, 277.e1-4; discussion 275-7. doi: 10.1016/j.jtcvs.2012.09.071. Epub 2012 Oct 25.

Mechanisms and consequences of inflammatory signaling in the myocardium.心肌炎症信号转导的机制及后果。

Curr Hypertens Rep. 2012 Dec;14(6):510-6. doi: 10.1007/s11906-012-0309-0.

Changes in the myocardial interstitium and contribution to the progression of heart failure.心肌间质的变化及其对心力衰竭进展的贡献。

Heart Fail Clin. 2012 Jan;8(1):7-20. doi: 10.1016/j.hfc.2011.08.012.

Matrix metalloproteinase therapy in heart failure.心力衰竭中的基质金属蛋白酶疗法。

Curr Treat Options Cardiovasc Med. 2009 Aug;11(4):339-46. doi: 10.1007/s11936-009-0034-4.

Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.抑制基质金属蛋白酶可改善心肌梗死后缺乏骨桥蛋白的小鼠的左心室功能。

Mol Cell Biochem. 2009 Feb;322(1-2):53-62. doi: 10.1007/s11010-008-9939-6. Epub 2008 Nov 1.

Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).年龄对血浆基质金属蛋白酶（MMPs）和金属蛋白酶组织抑制剂（TIMPs）的影响。

J Card Fail. 2007 Sep;13(7):530-40. doi: 10.1016/j.cardfail.2007.04.010.

MMPs as therapeutic targets--still a viable option?基质金属蛋白酶作为治疗靶点——仍是一个可行的选择吗？

Semin Cell Dev Biol. 2008 Feb;19(1):61-8. doi: 10.1016/j.semcdb.2007.06.006. Epub 2007 Jul 6.

Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.尿激酶型纤溶酶原激活物（uPA）或基质金属蛋白酶-9（MMP-9）的缺失或抑制可减轻小鼠急性压力超负荷后的左心室重构和功能障碍。

Am J Pathol. 2005 Jan;166(1):15-25. doi: 10.1016/S0002-9440(10)62228-6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验